instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
U.S. scientists said the infection in a 49-year-old Pennsylvania woman “heralds the emergence of truly pan-drug resistant bacteria” because it could not be controlled even by colistin, an antibiotic reserved for “nightmare” bugs. In Japan, British Prime Minister David Cameron said leading countries needed to tackle resistance by reducing the use of antibiotics and rewarding drug companies for developing new medicines. “In too many cases antibiotics have stopped working. That means people are dying of simple infections or conditions like TB (tuberculosis), tetanus, sepsis, infections that should not mean a death sentence,” he told a news conference at a summit in Japan. “If we do nothing about this there will be a cumulative hit to the world economy of $100 trillion and it is potentially the end of modern medicine as we know it.”  A review commissioned by the British government and published last week said a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market. If the problem is not brought under control, antimicrobial resistance could kill an extra 10 million people a year by 2050, the review warned. The U.S. case is a further wake-up call for the world, although it is not the first time that colistin resistance has appeared. Medics around were alarmed last year by the discovery in China of a new gene that makes bacteria highly resistant to the medicine. Since then, the deadly strain has also been detected in Europe and Canada. The development of colistin resistance is linked to the drug’s widespread use in livestock and the European Medicines Agency on Thursday called for a 65 percent cut in the amount of the medicine used in farming. “The more we look at drug resistance, the more concerned we are,” Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, told reporters in Washington. “The medicine cabinet is empty for some patients. It is the end of the road for antibiotics unless we act urgently.”  The problem is aggravated by drugmakers’ reluctance to invest in developing new antibiotics, preferring to focus on more profitable disease areas, although recently there has been some increase in investment, prompted by the superbug threat. In January, 83 companies, including Pfizer (PFE.N), Merck & Co (MRK.N), Johnson & Johnson (JNJ.N) and GlaxoSmithKline (GSK.L), signed a declaration urging governments to support work on new antibiotics.
answer:
G7 told to act on antibiotics as dreaded superbug hits U.S.


question:
The Kansas Department of Health and Environment announced Thursday that students entering kindergarten and first grade will need two doses of a hepatitis A vaccine. Students entering seventh grade will need one dose of the meningococcal ACWY vaccine. And students starting their junior year will need the meningococcal ACWY vaccine if they have not been vaccinated before their 16th birthday. The new requirements take effect Aug. 2. Kansas allows exemptions from vaccines only for medical and religious reasons. Health department Secretary Lee Norman said the agency collected public input before proposing the new requirements. He said meningitis and hepatitis A are both severe diseases that are preventable with vaccines.
answer:
2 new vaccines required for some Kansas school students.


question:
The French drugmaker said it was working with health authorities to determine the level and extent of the recall, which it called a precautionary measure being taken due to possible contamination with a substance called N-nitrosodimethylamine (NDMA). Sanofi has sold over-the-counter Zantac in the U.S. and Canada since 2017. It is pulling the drug off shelves after previous recalls by some manufacturers of generic versions of the drug. Sanofi reported Zantac sales of 127 million euros in 2018 69 million euros over the first half of 2019. U.S. and European health regulators said last month they were reviewing the safety of ranitidine, which is commonly sold as Zantac and its generic alternatives, after an online pharmacy called Valisure notified them that it had found impurities in the drugs. The U.S. Food and Drug Administration said earlier this month it found unacceptable levels of NDMA in drugs containing ranitidine. The regulator asked ranitidine makers to conduct their own testing to assess levels of the impurity and to send samples of their products for testing by the agency. Canada has requested drugmakers halt distribution of the drug while it gathers more information. Sanofi CEO Paul Hudson, speaking at a press conference in Framingham, Mass., earlier this week, downplayed concerns about the drug. “We don’t believe there’s a risk,” Hudson said on Tuesday. “But we have to - and are appropriately duty bound to - satisfy the regulators, which we will do, and we’ll move on from there.”  Other drugmakers including GlaxoSmithKline and  Novartis have recalled or halted distribution of their versions of the drug. Retailers and pharmacy chains including Walmart Inc CVS Health Corp, Walgreens Boots Alliance Inc and Rite Aid Corp have suspended the sale of drugs containing ranitidine. The FDA has said it does not have enough scientific evidence yet to determine how long NDMA has been present in ranitidine. But Valisure - the online pharmacy that flagged the issue to regulators - believes the problem is inherent to the drug itself and NDMA may have been present as long as its been on the market. Ranitidine is the latest drug in which cancer-causing impurities have been found. Regulators have been recalling some blood pressure and heart failure medicines since last year.
answer:

I have never supported cap and trade.